Study: A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer
Phase III
· Site: SITE009 (AUS) (Dr. Novak)
· consented 2023-07-29
Adverse events
3
Serious AEs
2
Open data queries
0
Luna dropout signal
–
Adverse events
severe
serious
assessed
2026-08-18
Grade 4 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2023-09-02 (study day 28); relationship: not assessed; serious criteria: life-threatening
moderate
assessed
2026-08-18
Grade 2 Fatigue — outcome: RECOVERED/RESOLVED; onset 2023-11-24 (study day 111); relationship: not assessed
severe
serious
assessed
2026-08-18
Grade 4 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2024-01-16 (study day 164); relationship: N; serious criteria: life-threatening
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.